Delivery Order SPE2DB20D3103-SPE2DB25FM8J3

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $27,992.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565405069 ADACEL TDAP SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of August 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type and has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award is for the delivery of ADACEL TDAP VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $2,906.34 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 31, 2024, with a completion date of June 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,157.00, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a contract value of $1,949.73 and an ultimate completion date of February 6, 2025. It is a firm-fixed-price delivery order contract to provide ADACEL TDAP VIAL 0.5ML, a vaccine product, to support military healthcare programs. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,317.45 Firm Fixed Price Delivery Order is for the supply of ADACEL TDAP VIAL 0.5ML, a vaccine product. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen is the prime contractor for this award, which is not designated as a set-aside contract. The company holds a significant...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM8T3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $18,244.40 firm fixed-price delivery order is for the supply of 4563827408 ADACEL TDAP SYRINGE 0.5ML, with a completion date of March 4, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,308.24 Firm Fixed Price Delivery Order is for the supply of ADACEL TDAP SYRINGE 5S, a medical product, with a period of performance through November 26, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,565.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADACEL SDV 0.5ML 10S medical supplies, with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4564387960 ADACEL TDAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $13,512.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 24, 2024. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,116.44, is for the delivery of ADACEL SDV 0.5ML 10S medical supplies. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM8J3
    Delivery Order

This federal contract award, valued at $32,831.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The specific contract award is for the delivery of ADACEL TDAP SYRINGE 0.5ML, a medical product, with a performance period extending through February 2025. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:47 AM